Analysen zu GSK PLC Registered Shs
| 01.05.24 | GSK Buy | UBS AG | |
| 01.05.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.04.24 | GSK Buy | UBS AG | |
| 24.04.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | GSK Outperform | Bernstein Research | |
| 08.04.24 | GSK Equal Weight | Barclays Capital | |
| 04.04.24 | GSK Equal Weight | Barclays Capital | |
| 03.04.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 20.03.24 | GSK Buy | Jefferies & Company Inc. | |
| 19.03.24 | GSK Buy | UBS AG | |
| 18.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.03.24 | GSK Buy | UBS AG | |
| 27.02.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.02.24 | GSK Buy | Deutsche Bank AG | |
| 15.02.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.02.24 | GSK Buy | UBS AG | |
| 09.02.24 | GSK Buy | Jefferies & Company Inc. | |
| 08.02.24 | GSK Buy | Deutsche Bank AG | |
| 06.02.24 | GSK Buy | UBS AG | |
| 05.02.24 | GSK Buy | Deutsche Bank AG | |
| 02.02.24 | GSK Equal Weight | Barclays Capital | |
| 01.02.24 | GSK Halten | DZ BANK | |
| 01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Buy | UBS AG | |
| 30.01.24 | GSK Buy | UBS AG | |
| 16.01.24 | GSK Buy | Jefferies & Company Inc. | |
| 15.01.24 | GSK Buy | UBS AG | |
| 15.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 10.01.24 | GSK Buy | Deutsche Bank AG | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Sell | UBS AG | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.01.24 | GSK Buy | Jefferies & Company Inc. | |
| 27.12.23 | GSK Equal Weight | Barclays Capital | |
| 19.12.23 | GSK Buy | Deutsche Bank AG | |
| 15.12.23 | GSK Buy | Deutsche Bank AG | |
| 06.12.23 | GSK Buy | Deutsche Bank AG | |
| 05.12.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.12.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.12.23 | GSK Buy | Deutsche Bank AG | |
| 28.11.23 | GSK Buy | Deutsche Bank AG | |
| 22.11.23 | GSK Hold | Jefferies & Company Inc. | |
| 16.11.23 | GSK Hold | Jefferies & Company Inc. | |
| 08.11.23 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Aktuelle Aktienanalysen
| 05.09.25 | Tesla Sell | UBS AG | |
| 05.09.25 | Orsted Neutral | JP Morgan Chase & Co. | |
| 05.09.25 | BBVA Buy | Jefferies & Company Inc. | |
| 05.09.25 | Airbus Outperform | RBC Capital Markets | |
| 05.09.25 | Broadcom Buy | UBS AG | |
| 05.09.25 | Novartis Neutral | UBS AG | |
| 05.09.25 | Novo Nordisk Neutral | UBS AG | |
| 05.09.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 05.09.25 | freenet Buy | Warburg Research | |
| 05.09.25 | Bechtle Buy | Deutsche Bank AG | |
| 05.09.25 | Infineon Buy | Deutsche Bank AG | |
| 05.09.25 | Sanofi Buy | Deutsche Bank AG | |
| 05.09.25 | AIXTRON Hold | Deutsche Bank AG | |
| 05.09.25 | Airbus Buy | Jefferies & Company Inc. | |
| 05.09.25 | Orsted Sector Perform | RBC Capital Markets | |
| 05.09.25 | Orsted Hold | Jefferies & Company Inc. | |
| 05.09.25 | Walmart Buy | UBS AG | |
| 05.09.25 | UBM Development buy | Erste Group Bank | |
| 05.09.25 | ATOSS Software Buy | Deutsche Bank AG | |
| 05.09.25 | BAT Buy | UBS AG | |
| 05.09.25 | Hermès Neutral | UBS AG | |
| 05.09.25 | L'Oréal Neutral | UBS AG | |
| 05.09.25 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.25 | Sixt Buy | UBS AG | |
| 05.09.25 | RWE Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.25 | Schaeffler Neutral | UBS AG | |
| 05.09.25 | ASML NV Buy | UBS AG | |
| 05.09.25 | QIAGEN Buy | Jefferies & Company Inc. | |
| 05.09.25 | Infineon Neutral | JP Morgan Chase & Co. | |
| 04.09.25 | Sanofi Buy | Jefferies & Company Inc. | |
| 04.09.25 | Saint-Gobain Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | Iberdrola Sector Perform | RBC Capital Markets | |
| 04.09.25 | Sanofi Outperform | Bernstein Research | |
| 04.09.25 | L'Oréal Hold | Jefferies & Company Inc. | |
| 04.09.25 | HelloFresh Neutral | JP Morgan Chase & Co. | |
| 04.09.25 | RWE Outperform | RBC Capital Markets | |
| 04.09.25 | thyssenkrupp nucera Outperform | RBC Capital Markets | |
| 04.09.25 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | LVMH Moet Hennessy Louis Vuitton Hold | Jefferies & Company Inc. | |
| 04.09.25 | Allianz Underweight | Barclays Capital | |
| 04.09.25 | AXA Overweight | Barclays Capital | |
| 04.09.25 | Assicurazioni Generali Underweight | Barclays Capital | |
| 04.09.25 | Hannover Rück Underweight | Barclays Capital | |
| 04.09.25 | Münchener Rückversicherungs-Gesellschaft Overweight | Barclays Capital | |
| 04.09.25 | Swiss Re Underweight | Barclays Capital | |
| 04.09.25 | Zurich Insurance Equal Weight | Barclays Capital | |
| 04.09.25 | ASML NV Equal Weight | Barclays Capital | |
| 04.09.25 | Nordex Buy | Jefferies & Company Inc. | |
| 04.09.25 | Richemont Sector Perform | RBC Capital Markets | |
| 04.09.25 | adidas Outperform | RBC Capital Markets |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.